In summary the new fluorescent canine CT1258-EGFP-HMGA2 cell line provides a valuable tool for further investigations on HMGA2-mediated proliferative effects and HMGA2 regulation mechanisms elucidating the development and pathogenesis of canine prostate cancer. This evidence concerns the gene HMGA2 and prostate carcinoma.